Wintrust Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-69
Closed -$36K 448
2024
Q3
$36K Sell
69
-519
-88% -$277K 0.03% 360
2024
Q2
$319K Buy
588
+154
+35% +$81.4K 0.03% 365
2024
Q1
$225K Sell
434
-70
-14% -$34.8K 0.02% 433
2023
Q4
$238K Buy
504
+4
+0.8% +$1.85K 0.02% 392
2023
Q3
$218K Hold
500
0.02% 376
2023
Q2
$222K Sell
500
-8
-2% -$3.69K 0.02% 394
2023
Q1
$234K Sell
508
-3
-0.6% -$1.43K 0.03% 304
2022
Q4
$262K Buy
511
+11
+2% +$5.58K 0.03% 308
2022
Q3
$227K Sell
500
-100
-17% -$47.8K 0.03% 361
2022
Q2
$290K Hold
600
0.03% 305
2022
Q1
$295K Hold
600
0.03% 334
2021
Q4
$278K Hold
600
0.03% 350
2021
Q3
$224K Hold
600
0.03% 252
2021
Q2
$229K Buy
+600
New +$229K 0.02% 389
2019
Q2
Sell
-750
Closed -$215K 366
2019
Q1
$215K Sell
750
-50
-6% -$14.5K 0.03% 325
2018
Q4
$210K Hold
800
0.04% 308
2018
Q3
$219K Sell
800
-50
-6% -$13K 0.04% 331
2018
Q2
$202K Buy
+850
New +$197K 0.04% 338
2018
Q1
Sell
-1,850
Closed -$416K 272
2017
Q4
$416K Sell
1,850
-100
-5% -$21.3K 0.1% 183
2017
Q3
$370K Sell
1,950
-175
-8% -$33.3K 0.09% 193
2017
Q2
$400K Sell
2,125
-100
-4% -$18K 0.11% 194
2017
Q1
$368K Buy
+2,225
New +$354K 0.1% 195

Other funds holding ELV

Wintrust Investments's ELV Position: Q4 2024 in Review

Wintrust Investments sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 69 shares — an estimated $36K sold.

Wintrust Investments first reported a position in ELV in Q1 2017 and held it in 22 quarters. The position peaked at $416K in Q4 2017. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Wintrust Investments reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Wintrust Investments sold 69 Elevance Health shares in Q4 2024, an estimated $36K.
  • Wintrust Investments first reported a position in Elevance Health in Q1 2017 and held it in 22 quarters.
  • Wintrust Investments's Elevance Health position peaked at $416K in Q4 2017.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.